．

Material Information - The Company Announces Submission of Marketing Authorization Application of BESREMi (Ropeginterferon alfa-2b) for PV in Vietnam

Apr 1, 2025

20250401 本公司新藥BESREMi申請越南上市許可證，適應症為PV (EN).pdf

Download